Intravenous Immunoglobulin Market: Industry Expert View on Future Growth and Market Trends
Immunoglobulins are the antibodies produced naturally by the body’s immune system, which help fight infection and disease. The deficiency of immunoglobulin requires the external administration of immunoglobulin and is known as immunoglobulin replacement therapy (IgRT). IgRT can be given intravenously and subcutaneously. Intravenous immunoglobulin (IVIg) and subcutaneous immunoglobulin (SCIg) are selected based on the indication and severity. IVIg is manufactured from human plasma. It contains antibodies and is used in the treatment of a growing number of immunologic, hematologic, and neurologic illnesses. Key factors that are driving the growth of the North American intravenous immunoglobulin market are the increasing prevalence of immunodeficiency diseases and the increasing geriatric population drives the growth of the intravenous immunoglobulin market. However, the market is likely to get impacted by the adverse effects of immunoglobulin therapy during the forecast period. North Am...